Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) traded at $16.98 at close of the session on Monday, July 22, made an upward move of 1.01% on its previous day’s price.
Looking at the stock we see that its previous close was $16.81 . In terms of its 52-week price range, TEVA has a high of $17.69 and a low of $8.06. The company’s stock has lost about -0.47% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Teva- Pharmaceutical Industries Ltd. ADR has a market cap of $19.23 billion.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the TEVA stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 100% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is 2.41% off its SMA20 and 1.71% from its 50-day simple moving average. The RSI (14) is pointing at 55.06 while the volatility over the past week is 3.17% and jumps to 2.89% over the past one month. The beta value is 0.90, while the average true range (ATR) is currently pointing at 0.50.
Coming back to Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA), we note that the average 3-month trading volume was 9.93 million. Current shares outstanding are 1.13 billion.
The insiders hold 0.01% of the company’s shares while institutions hold 52.67%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 62.64% up in year-to-date price movement.